We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$48.5M
Cap. Flow
+$27.1M
Cap. Flow %
9.94%
Top 10 Hldgs %
21.2%
Holding
121
New
13
Increased
46
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$3.1M
2
MRVL icon
Marvell Technology
MRVL
+$3.02M
3
VEEV icon
Veeva Systems
VEEV
+$2.97M
4
QTRX icon
Quanterix
QTRX
+$2.96M
5
SOFI icon
SoFi Technologies
SOFI
+$2.56M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$2.98M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.86M
3
ILMN icon
Illumina
ILMN
+$2.18M
4
RGNX icon
Regenxbio
RGNX
+$2.05M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 44.35%
2 Healthcare 32.32%
3 Financials 8.79%
4 Industrials 7.11%
5 Consumer Discretionary 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
76
Kymera Therapeutics
KYMR
$9.1B
$1.31M 0.48%
+26,958
New +$1.17M
ACAD icon
77
Acadia Pharmaceuticals
ACAD
$4.25B
$1.31M 0.48%
53,527
+5,373
+11% +$121K
NVDA icon
78
NVIDIA
NVDA
$5.01T
$1.29M 0.47%
258,120
-5,840
-2% -$93.6K
BAH icon
79
Booz Allen Hamilton
BAH
$8.7B
$1.28M 0.47%
15,007
-2,222
-13% -$188K
RPD icon
80
Rapid7
RPD
$634M
$1.23M 0.45%
12,973
-730
-5% -$61.5K
EXAS
81
DELISTED
Exact Sciences
EXAS
$1.21M 0.45%
9,769
+109
+1% +$13K
VRNS icon
82
Varonis Systems
VRNS
$5.25B
$1.2M 0.44%
20,881
-907
-4% -$47.2K
FIS icon
83
Fidelity National Information Services
FIS
$21.5B
$1.18M 0.43%
8,302
-342
-4% -$50.8K
SGEN
84
DELISTED
Seagen Inc. Common Stock
SGEN
$1.15M 0.42%
7,270
+812
+13% +$121K
TDY icon
85
Teledyne Technologies
TDY
$30.4B
$1.11M 0.41%
2,655
-266
-9% -$113K
XLRN
86
DELISTED
Acceleron Pharma
XLRN
$1.1M 0.4%
+8,798
New +$1.11M
COHR icon
87
Coherent
COHR
$55.2B
$1.09M 0.4%
15,049
-360
-2% -$25.3K
BFLY icon
88
Butterfly Network
BFLY
$1.72B
$1.08M 0.4%
74,796
-4,720
-6% -$63.7K
ADPT icon
89
Adaptive Biotechnologies
ADPT
$3.56B
$1.07M 0.39%
+26,249
New +$1.02M
NBIX icon
90
Neurocrine Biosciences
NBIX
$17.7B
$1.06M 0.39%
10,903
-17,510
-62% -$1.68M
ZBRA icon
91
Zebra Technologies
ZBRA
$12.4B
$1.04M 0.38%
1,973
-77
-4% -$38.4K
BNR
92
Burning Rock Biotech
BNR
$1.04M 0.38%
3,544
-21
-0.6% -$6.21K
MANT
93
DELISTED
Mantech International Corp
MANT
$1.04M 0.38%
12,051
-1,662
-12% -$144K
BPMC
94
DELISTED
Blueprint Medicines
BPMC
$1M 0.37%
11,397
+2,674
+31% +$245K
NOW icon
95
ServiceNow
NOW
$102B
$1M 0.37%
9,105
-235
-3% -$23.8K
IRDM icon
96
Iridium Communications
IRDM
$4.85B
$971K 0.36%
24,279
-2,144
-8% -$83.3K
RARE icon
97
Ultragenyx Pharmaceutical
RARE
$2.65B
$969K 0.36%
10,165
-10,852
-52% -$1.13M
BL icon
98
BlackLine
BL
$1.69B
$955K 0.35%
8,579
+889
+12% +$97.1K
AFRM icon
99
Affirm
AFRM
$23.5B
$930K 0.34%
13,814
-6,274
-31% -$400K
MNTS icon
100
Momentus
MNTS
$88.7M
$928K 0.34%
5
-1
-17% -$146K
1 2 3
4
5

Similar funds

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
SC
Sonen Capital San Francisco, California $52.7M AUM 25.58% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
ACJ
Autonomy Capital (Jersey) St. Helier, Jersey $54.8M AUM 37.27% 1-Year Est. Return
UFG
United Fire Group Cedar Rapids, Iowa $55M AUM 6% 1-Year Est. Return
KC
Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return

AtonRa Partners's Q2 2021 Portfolio in Review

As of Q2 2021, AtonRa Partners held 121 positions worth $273M, up 22% from $224M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AtonRa Partners deployed $27.1M of net new capital in Q2 2021, opening 13 new positions and adding to 46 existing holdings. Its largest new stake was Marvell Technology: 61,809 shares worth $3.6M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 41% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Guardant Health, an estimated $2.98M trimmed.

  • AtonRa Partners's largest Q2 2021 buy was Marvell Technology: 61,809 shares worth $3.6M.
  • AtonRa Partners added most to SolarEdge in Q2 2021, an estimated $3.1M increase.
  • AtonRa Partners's biggest Q2 2021 reduction was Guardant Health, cutting an estimated $2.98M.
  • AtonRa Partners fully exited Vertex Pharmaceuticals in Q2 2021, selling an estimated $2.86M.
  • AtonRa Partners's ten largest holdings make up 21% of its $273M portfolio in Q2 2021.
  • AtonRa Partners opened 13 new positions and closed 9 in Q2 2021.
  • AtonRa Partners's portfolio value rose 22% quarter-over-quarter to $273M.

Based on AtonRa Partners's 13F filing for Q2 2021, filed 12 Aug 2021.